At the occasion of the World Congress of Cardiology in Barcelona, from September 2 until 6, Agfa HealthCare will demonstrate its leading cardiology solution: Agfa Heartlab Cardiovascular. The event also marks the European debut of Heartlab Congenital, the world's most comprehensive and flexible reporting and analysis tool for congenital echocardiography reporting. Agfa HealthCare announces that it will start the first implementation phase of its ORBIS⢠hospital IT solution at the Belgian AZ Groeninge hospital in Kortrijk and the AZ Imelda Hospital in Bonheiden. 
The current Pinnacle system combines AcQSim simulation, Syntegra image fusion and P3IMRT modules to provide a powerful oncology toolbox capable of sculpting radiation doses to tumors. The new MBS software offers a revolutionary advancement in reducing the time it takes to contour tumors and anatomical structures and is a crucial step toward the future of IGRT and the ability to quickly adapt patients' treatment plans based on their response to daily treatment. The system makes it more difficult for counterfeit drugs to get to market, protecting consumers by helping ensure the drugs they receive match the prescription from their physician.
The three finalists of the EUROPEAN BIOTECHNICA AWARD 2006 have been announced. The international jury of nine experts has nominated biotechnology companies from Germany, Austria and Denmark for the Award, which is worth a total of 40,000 euros in prize money. The jury selected the finalists from a field of 16 outstanding candidates from eight countries. Royal Philips Electronics announced its intent for capital allocation following the divestment of an 80.1% majority share in its Semiconductor unit. The transaction, announced separately today, values this business at around EUR 8.3 billion.